Publications dans lesquelles il/elle collabore avec VICTOR MANUEL VICTOR GONZALEZ (17)

2024

  1. Interference with mitochondrial function as part of the antifibrogenic effect of Rilpivirine: A step towards novel targets in hepatic stellate cell activation

    Biomedicine and Pharmacotherapy, Vol. 178

2023

  1. Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

    Biomedicine and Pharmacotherapy, Vol. 167

2021

  1. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?

    Journal of Pathology, Vol. 254, Núm. 3, pp. 216-228

2019

  1. Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack

    Antiviral Research, Vol. 168, pp. 36-50

2016

  1. The purine analogues abacavir and didanosine increase acetaminophen-induced hepatotoxicity by enhancing mitochondrial dysfunction

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 916-926

2015

  1. Mitochondrial (dys)function - A factor underlying the variability of efavirenz-induced hepatotoxicity?

    British Journal of Pharmacology, Vol. 172, Núm. 7, pp. 1713-1727

2013

  1. ER stress in human hepatic cells treated with Efavirenz: Mitochondria again

    Journal of Hepatology, Vol. 59, Núm. 4, pp. 780-789

2010

  1. Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells

    Hepatology, Vol. 52, Núm. 1, pp. 115-125

2009

  1. Mitochondrial-targeted antioxidants and oxidative stress: A proteomic prospective study

    Current Pharmaceutical Design, Vol. 15, Núm. 26, pp. 3052-3062

  2. Oxidative stress and mitochondrial dysfunction in sepsis: A potential therapy with mitochondria-targeted antioxidants

    Infectious Disorders - Drug Targets, Vol. 9, Núm. 4, pp. 376-389

  3. Regulation of oxygen distribution in tissues by endothelial nitric oxide

    Circulation Research, Vol. 104, Núm. 10, pp. 1178-1183

2008

  1. Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 30, pp. 10507-10512

2006

  1. Complex I dysfunction and tolerance to nitroglycerin: An approach based on mitochondrial-targeted antioxidants

    Circulation Research, Vol. 99, Núm. 10, pp. 1067-1075

  2. Endothelial Nitric Oxide Synthase Regulates T Cell Receptor Signaling at the Immunological Synapse

    Immunity, Vol. 24, Núm. 6, pp. 753-765

  3. Loss of apoptosis-inducing factor leads to an increase in reactive oxygen species, and an impairment of respiration that can be reversed by antioxidants [4]

    Cell Death and Differentiation

2005

  1. Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO

    Circulation Research, Vol. 97, Núm. 10, pp. 1063-1069

  2. Role of free radicals in sepsis: Antioxidant therapy

    Current Pharmaceutical Design, Vol. 11, Núm. 24, pp. 3141-3158